Did anyone notice this from the press release this

Quote:

---

Our plan is to conduct a small [Kevetrin] trial that will provide the critical data necessary to forge a partnership with a large pharmaceutical company that could potentially fund development of Kevetrin through FDA approval. We are encouraged by the guidance and feedback that we have received from potential partners which are incorporated in our Phase 2a trial design.

---